Renovacare Stock Performance
| RCAR Stock | USD 0.0001 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and RenovaCare are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days RenovaCare has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, RenovaCare is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 7.4 M | |
| Free Cash Flow | -4.6 M |
RenovaCare |
RenovaCare Relative Risk vs. Return Landscape
If you would invest 0.01 in RenovaCare on September 3, 2024 and sell it today you would earn a total of 0.00 from holding RenovaCare or generate 0.0% return on investment over 90 days. RenovaCare is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than RenovaCare, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
RenovaCare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for RenovaCare's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as RenovaCare, and traders can use it to determine the average amount a RenovaCare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| RCAR |
Based on monthly moving average RenovaCare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RenovaCare by adding RenovaCare to a well-diversified portfolio.
RenovaCare Fundamentals Growth
RenovaCare Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of RenovaCare, and RenovaCare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RenovaCare Pink Sheet performance.
| Return On Equity | -5.69 | |||
| Return On Asset | -1.04 | |||
| Current Valuation | 3.42 M | |||
| Shares Outstanding | 87.35 M | |||
| Price To Earning | (85.28) X | |||
| Price To Book | 5.11 X | |||
| EBITDA | (4.46 M) | |||
| Cash And Equivalents | 243.96 K | |||
| Total Debt | 800 K | |||
| Debt To Equity | 1.00 % | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (4.56 M) | |||
| Earnings Per Share | (0.07) X | |||
| Total Asset | 3.65 M | |||
| Retained Earnings | (10.59 M) | |||
| Current Asset | 700 K | |||
| Current Liabilities | 118 K | |||
About RenovaCare Performance
Assessing RenovaCare's fundamental ratios provides investors with valuable insights into RenovaCare's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the RenovaCare is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. Renovacare operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about RenovaCare performance evaluation
Checking the ongoing alerts about RenovaCare for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for RenovaCare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RenovaCare generated a negative expected return over the last 90 days | |
| RenovaCare has some characteristics of a very speculative penny stock | |
| RenovaCare currently holds 800 K in liabilities with Debt to Equity (D/E) ratio of 1.0, which is about average as compared to similar companies. RenovaCare has a current ratio of 0.73, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist RenovaCare until it has trouble settling it off, either with new capital or with free cash flow. So, RenovaCare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RenovaCare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RenovaCare to invest in growth at high rates of return. When we think about RenovaCare's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (4.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| RenovaCare currently holds about 243.96 K in cash with (4.56 M) of positive cash flow from operations. | |
| Roughly 74.0% of RenovaCare outstanding shares are owned by corporate insiders |
- Analyzing RenovaCare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RenovaCare's stock is overvalued or undervalued compared to its peers.
- Examining RenovaCare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RenovaCare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of RenovaCare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RenovaCare's pink sheet. These opinions can provide insight into RenovaCare's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for RenovaCare Pink Sheet Analysis
When running RenovaCare's price analysis, check to measure RenovaCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovaCare is operating at the current time. Most of RenovaCare's value examination focuses on studying past and present price action to predict the probability of RenovaCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovaCare's price. Additionally, you may evaluate how the addition of RenovaCare to your portfolios can decrease your overall portfolio volatility.